A Review of the Treatment Options

Benedetta Sonego,Andrea Corio,Vanessa Mazzoletti,Verena Zerbato,Alessandro Benini,Nicola di Meo,Iris Zalaudek,Giuseppe Stinco,Enzo Errichetti,Enrico Zelin
DOI: https://doi.org/10.3390/jcm13123558
IF: 3.9
2024-06-19
Journal of Clinical Medicine
Abstract:Background: Dermatophytosis is a prevalent superficial infection caused by filamentous fungi, primarily affecting the skin and/or its appendages. In recent years, there has been a notable increase in mycotic strains resistant to standard antifungal therapies, including Trichophyton indotineae, a dermatophyte of the Trichophyton mentagrophytes complex. This review aims to provide a comprehensive overview of the treatment options for T. indotineae, elucidating their effectiveness in managing this challenging mycotic infection. Methods: For this review, a search was conducted in the PubMed, Scopus, Web of Science, Embase, and Google Scholar databases, encompassing all published data until March 2024. English-language articles detailing therapy outcomes for patients confirmed to be affected by T. indotineae, identified through molecular analysis, were included. Results: Itraconazole was shown to be a good therapeutic choice, particularly when administered at a dosage of 200 mg/day for 1–12 weeks. Voriconazole was also demonstrated to be effective, while terbinafine exhibited a reduced response rate. Griseofulvin and fluconazole, on the other hand, were found to be ineffective. Although topical treatments were mostly ineffective when used alone, they showed promising results when used in combination with systemic therapy. Mutational status was associated with different profiles of treatment response, suggesting the need for a more tailored approach. Conclusions: When managing T. indotineae infections, it is necessary to optimize therapy to mitigate resistances and relapse. Combining in vitro antifungal susceptibility testing with mutational analysis could be a promising strategy in refining treatment selection.
medicine, general & internal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is about the treatment options for **Trichophyton indotineae** (an emerging drug - resistant dermatophyte) and their effectiveness. Specifically, the paper aims to provide a comprehensive review, covering the treatment regimens that are effective in the management of this challenging fungal infection. The paper mentions that in recent years, there have been an increasing number of fungal strains resistant to standard antifungal therapies, especially **Trichophyton indotineae**, which makes the search for effective treatment methods particularly important. ### Background of the paper - **Dermatophytosis** is a common superficial fungal infection, mainly affecting the skin and its appendages. - In recent years, many strains resistant to antifungal drugs have emerged, among which **Trichophyton indotineae** is particularly prominent. - This strain belongs to the **Trichophyton mentagrophytes** complex and is characterized by being prone to developing drug resistance, resulting in difficult treatment. ### Research objectives - **Review treatment options**: Systematically review and evaluate the existing methods for treating **Trichophyton indotineae** infections. - **Evaluate efficacy**: Analyze the effectiveness of different treatment regimens, especially the treatment effects for resistant strains. - **Make recommendations**: Based on the existing data, make suggestions for optimizing treatment strategies to reduce drug resistance and recurrence rates. ### Main findings - **Itraconazole**: Proven to be a better treatment choice, especially when used at a dose of 200 mg per day for 1 to 12 weeks. - **Voriconazole**: Also proven to be effective, but is used less frequently. - **Terbinafine**: Has a lower response rate, especially in resistant strains. - **Griseofulvin** and **Fluconazole**: Are almost ineffective. - **Topical treatment**: Has a poor effect when used alone, but shows good results when combined with systemic treatment. ### Conclusion - When managing **Trichophyton indotineae** infections, treatment regimens need to be optimized to reduce drug resistance and recurrence. - Combining in vitro antifungal susceptibility testing and mutation analysis may help to select treatment regimens more precisely. Through these studies, the paper provides valuable references for clinicians, helping them better deal with this increasingly serious drug - resistant fungal infection.